AstraZeneca(AZN) - 2023 Q4 - Earnings Call Transcript

AstraZeneca PLC (NASDAQ:AZN) Q4 2023 Earnings Conference Call February 8, 2024 6:45 AM ET Company Participants Andy Barnett - Head, IR Pascal Soriot - CEO Aradhana Sarin - CFO David Fredrickson - EVP, Oncology Business Susan Galbraith - EVP, Oncology R&D Ruud Dobber - EVP, BioPharmaceuticals Business Sharon Barr - EVP, BioPharmaceuticals R&D Marc Dunoyer - CEO, Alexion Iskra Reic - EVP of Vaccines & Immune Therapies Conference Call Participants James Gordon - JP Morgan Emily Field - Barclays Matthew Weston ...